Alto Ingredients, Inc. (ALTO)
Last Price$1.4(0.7%)
Market Cap$101.5M
ALTO Rating
ALTO Quality rating performance
ALTO Intrinsic Value
Key Highlights:
As of Mar 11, 2025 ALTO Relative Value is $23.3, which is undervalued by 1,563.5%, compared to current share price of $1.4.
As of Mar 11, 2025 ALTO DCF Value is N/A, which is undervalued by N/A, compared to current share price of $1.4.
ALTO Share Price History
1W (2.8%)
1M (2.8%)
6M 0.0%
YTD (47.8%)
1Y (36.9%)
3Y (77.2%)
5Y 352.6%
10Y (86.9%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
ALTO Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$101.5M
$106.4M
$965.3M
($3,519.0K)
Shares Outstanding
73M
Employees
N/A
Growth (CAGR)
(7.5%)
(7.3%)
(15.32%)
(33.3%)
(2.0%)
(63.41%)
Profitability
1.1%
(5.3%)
(6.1%)
0.6%
(0.4%)
20.4%
Intrinsic Value
$23.7 (1,591.5% undervalued)
N/A
$23.7
(100.0%)
(453.7%)
Valuation (LTM)
Return on Capital
Financial Health
$4,851.0K
(1.4x)
(19.0x)
(2.8%)
Dividends
(8.1%)
0.9%
(27.0%)
Earnings
Aug 04, 2025
BEAT by 5.7%
MISS by 50.0%
60.0%
4 Beat & 6 Miss
ALTO Stock Financials
ALTO Income Statement Metrics
Annual
Quarterly
LTM
ALTO Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
N/A -71.5% YoY
Capital Expenditure (CAPEX)
N/A -66.9% YoY
Free Cash Flow (FCF)
N/A -53.1% YoY
ALTO Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
ALTO Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
N/A
Current assets (N/A, N/A of total)
Non-current assets (N/A, N/A of total)
N/A (N/A)
N/A (N/A)
N/A (N/A)
Other non-current assets
N/A (N/A)
Financial position
$0.0
Cash & Short-term
Investments
Total Debt
ALTO Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
ALTO Earnings Surprises
Crunching data... Almost there!
ALTO Dividends
ALTO Dividend Yield
Crunching data... Almost there!
ALTO Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with ALTO
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$101.5M | 4.5 | $23.7 1,591.5% undervalued | (36.9%) | $965.3M | ($3,519.0K) | (21.1%) | (0.4%) | 1.1% | (35.6%) | (2.8%) | |
$218.3B | 6.6 | $281.1 38.1% overvalued | (2.1%) | $33.0B | $4,926.0M | (11.5%) | 14.9% | 42.2% | 9.8% | 56.7% | |
$89.8B | 6.8 | $140.3 60.2% overvalued | 4.6% | $23.1B | $2,083.2M | 0.2% | 9.0% | 48.5% | 15.7% | 294.1% | |
$74.7B | 6.9 | $124.2 52.0% overvalued | 16.8% | $15.7B | $1,819.4M | 2.7% | 11.6% | 43.5% | 13.2% | 92.6% | |
$66.4B | 6.3 | $169.4 43.2% overvalued | 23.4% | $12.0B | ($1,519.4M) | (3.1%) | (12.6%) | 32.5% | 12.9% | 80.2% | |
$32.0B | 5.9 | $57.5 24.7% overvalued | 7.8% | $12.4B | $1,748.0M | 0.5% | 14.1% | 36.4% | (1.5%) | 30.1% | |
$26.3B | 5.2 | $111.5 1.7% overvalued | (18.6%) | $15.8B | $699.0M | (13.2%) | 4.4% | 39.7% | 10.1% | 91.9% | |
$24.0B | 4.9 | $201.9 173.0% undervalued | (23.3%) | $40.4B | $1,980.0M | (3.4%) | 4.9% | 11.1% | 6.2% | 102.7% | |
$20.5B | 5.8 | $70.9 11.2% overvalued | 0.3% | $11.5B | $602.0M | 0.0% | 5.2% | 33.1% | 4.2% | 69.0% | |
$15.1B | 6.2 | $88.2 25.1% overvalued | 1.8% | $7,345.3M | $656.6M | 0.1% | 8.9% | 41.4% | 14.3% | 85.8% | |
$13.9B | 5.2 | $214.3 97.3% undervalued | (22.2%) | $12.1B | $306.0M | (3.2%) | 2.5% | 15.6% | 4.1% | 0.1% |
FAQ
What is Alto Ingredients, Inc. (ALTO) stock rating?
As of today, Alto Ingredients, Inc. has a stock rating of 5 (out of 10), which is considered Good.
is Alto Ingredients, Inc. (ALTO) a good stock to buy?
As of today, Alto Ingredients, Inc. has a Good stock rating, which is 1,591.5% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.